Resilience
Venture capital · La Jolla, California, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio2 active
1Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Lyell Immunopharma
28Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Lyell Immunopharma | Biotech | Active | Mar 20, 2020 | $493.0M |
| Generate Biomedicines | Biotech | Active | — | — |
| Passage Bio | Biotech | Public | Sep 6, 2019 | $110.0M |
Peer ranks
Portfolio size#136
Portfolio exits#160
Raises, 12 months#88
Co-investors#64
Co-investors
- ARCH VentureVenture capital2 shared
- Foresite CapitalVenture capital2 shared
- GVVenture capital2 shared
- Perceptive AdvisorsVenture capital2 shared
- Third Rock VenturesVenture capital2 shared
- Amgen VenturesVenture capital1 shared
- Ascent Biomedical VenturesVenture capital1 shared
- Bessemer Venture PartnersVenture capital1 shared
- BioAdvanceVenture capital1 shared
- Boxer CapitalVenture capital1 shared
Sectors
- Biotech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.